Comments
Loading...
Blueprint Medicines (NASDAQ:BPMC) Stock, Earnings Estimates, EPS, And Revenue
Blueprint Medicines reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 13
EPS Estimate
$-0.860
Quarterly Revenue Estimate
$135.3M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$434.4M
Analyze the earnings history of Blueprint Medicines using advanced sorting and filters.
Data brought to you by Benzinga APIs
Blueprint Medicines (BPMC) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-10-30 | $-0.89 | $-0.96 | 7.29 % |
| Jun 2024 | 2024-08-01 | $-0.80 | $-1.29 | 38.0 % |
| Mar 2024 | 2024-05-02 | $-1.32 | $-1.66 | 20.5 % |
| Dec 2023 | 2024-02-15 | $-1.82 | $-2.04 | 10.8 % |
Blueprint Medicines (BPMC) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-10-30 | $128.18M | $127.03M | 0.91 % |
| Jun 2024 | 2024-08-01 | $138.16M | $103.00M | 34.1 % |
| Mar 2024 | 2024-05-02 | $96.12M | $80.43M | 19.5 % |
| Dec 2023 | 2024-02-15 | $71.96M | $66.64M | 7.98 % |
FAQ
When is Blueprint Medicines (NASDAQ:BPMC) reporting earnings?
Blueprint Medicines (BPMC) is scheduled to report earnings on February 13, 2025. The last reported earnings were for reported on October 30, 2024 for Q3.
What were the latest earnings per share (EPS) for Blueprint Medicines (NASDAQ:BPMC)?
The Actual EPS was $-0.89, which beat the estimate of $-0.96.
What were Blueprint Medicines’s (NASDAQ:BPMC) revenues?
The Actual Revenue was $128.2M, which beat the estimate of $127M.
Browse earnings estimates, EPS, and revenue on all stocks.